• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Recognized Consensus Standards

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

New Search Back To Search Results
Part B: Supplementary Information Sheet (SIS)
FR Recognition List Number 050 Date of Recognition 09/17/2018 
FR Recognition Number 7-280
Standard
CLSI M02 13th Edition
Performance Standards for Antimicrobial Disk Susceptibility Tests
Scope/Abstract
This standard describes the reference agar disk diffusion method used to determine the in vitro antimicrobial susceptibility of bacteria that grow aerobically and includes: agar plate preparation; testing conditions including inoculum preparation and standardization, incubation time, and incubation temperature; results interpretation; QC procedures; and disk diffusion method limitations.
Extent of Recognition
Complete standard
Rationale for Recognition
This standard is relevant to medical devices and is recognized on its scientific and technical merit and/or because it supports existing regulatory policies.
Transition Period
FDA recognition of CLSI M02-A12 [Rec# 7-258] will be superseded by recognition of CLSI M02 13th Edition [Rec# 7-280]. FDA will accept declarations of conformity, in support of premarket submissions, to [Rec# 7-258] until September 28, 2019. After this transition period, declarations of conformity to [Rec# 7-258] will not be accepted.
Public Law, CFR Citation(s) and Procode(s)
Regulation Number Device Name Device Class Product Code
§866.1620 Discs, Elution Class 2 LTX
§866.1620 Susceptibility Test Discs, Antimicrobial Class 2 JTN
Relevant FDA Guidance and/or Supportive Publications
Guidance for Industry and FDA Class II Special Controls Guidance Document: Antimicrobial Susceptibility Test (AST) Systems, Issued August 2009.
FDA Technical Contact
 Patricia Conville
  FDA/OMPT/CDRH/OIR/DMD/BAC1/
  301-796-6942
  patricia.conville@fda.hhs.gov
Standards Development Organization
CLSI Clinical Laboratory Standards Institute https://clsi.org/
FDA Specialty Task Group (STG)
InVitro Diagnostics
-
-